vs

Side-by-side financial comparison of Fluent, Inc. (FLNT) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

RIGEL PHARMACEUTICALS INC is the larger business by last-quarter revenue ($69.8M vs $61.8M, roughly 1.1× Fluent, Inc.). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs -6.7%, a 390.7% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs -5.5%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs -3.2%).

THG Fluently, formerly Language Connect, is a translation and language localisation service provided by THG Ingenuity. It provides a range of language services, including translation, interpreting, localisation, voice-overs, transcription, and multilingual search engine optimization.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

FLNT vs RIGL — Head-to-Head

Bigger by revenue
RIGL
RIGL
1.1× larger
RIGL
$69.8M
$61.8M
FLNT
Growing faster (revenue YoY)
RIGL
RIGL
+26.7% gap
RIGL
21.2%
-5.5%
FLNT
Higher net margin
RIGL
RIGL
390.7% more per $
RIGL
384.0%
-6.7%
FLNT
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
-3.2%
FLNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FLNT
FLNT
RIGL
RIGL
Revenue
$61.8M
$69.8M
Net Profit
$-4.1M
$268.1M
Gross Margin
91.5%
Operating Margin
0.3%
33.2%
Net Margin
-6.7%
384.0%
Revenue YoY
-5.5%
21.2%
Net Profit YoY
-20.1%
1769.2%
EPS (diluted)
$-0.09
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLNT
FLNT
RIGL
RIGL
Q4 25
$61.8M
$69.8M
Q3 25
$47.0M
$69.5M
Q2 25
$44.7M
$101.7M
Q1 25
$55.2M
$53.3M
Q4 24
$65.4M
$57.6M
Q3 24
$64.5M
$55.3M
Q2 24
$58.7M
$36.8M
Q1 24
$66.0M
$29.5M
Net Profit
FLNT
FLNT
RIGL
RIGL
Q4 25
$-4.1M
$268.1M
Q3 25
$-7.6M
$27.9M
Q2 25
$-7.2M
$59.6M
Q1 25
$-8.3M
$11.4M
Q4 24
$-3.4M
$14.3M
Q3 24
$-7.9M
$12.4M
Q2 24
$-11.6M
$-1.0M
Q1 24
$-6.3M
$-8.2M
Gross Margin
FLNT
FLNT
RIGL
RIGL
Q4 25
91.5%
Q3 25
93.2%
Q2 25
95.6%
Q1 25
91.7%
Q4 24
89.9%
Q3 24
85.5%
Q2 24
92.4%
Q1 24
93.1%
Operating Margin
FLNT
FLNT
RIGL
RIGL
Q4 25
0.3%
33.2%
Q3 25
-13.4%
40.9%
Q2 25
-15.9%
60.1%
Q1 25
-12.8%
23.9%
Q4 24
-8.3%
28.9%
Q3 24
-6.0%
25.4%
Q2 24
-17.7%
1.2%
Q1 24
-6.0%
-23.6%
Net Margin
FLNT
FLNT
RIGL
RIGL
Q4 25
-6.7%
384.0%
Q3 25
-16.1%
40.2%
Q2 25
-16.2%
58.6%
Q1 25
-15.0%
21.5%
Q4 24
-5.2%
24.9%
Q3 24
-12.3%
22.5%
Q2 24
-19.8%
-2.8%
Q1 24
-9.5%
-27.9%
EPS (diluted)
FLNT
FLNT
RIGL
RIGL
Q4 25
$-0.09
$14.11
Q3 25
$-0.27
$1.46
Q2 25
$-0.30
$3.28
Q1 25
$-0.39
$0.63
Q4 24
$-0.12
$0.82
Q3 24
$-0.48
$0.70
Q2 24
$-0.75
$-0.06
Q1 24
$-0.45
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLNT
FLNT
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$12.9M
$155.0M
Total DebtLower is stronger
$34.6M
$52.5M
Stockholders' EquityBook value
$18.2M
$391.5M
Total Assets
$89.1M
$513.6M
Debt / EquityLower = less leverage
1.90×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLNT
FLNT
RIGL
RIGL
Q4 25
$12.9M
$155.0M
Q3 25
$9.2M
$137.1M
Q2 25
$4.9M
$108.4M
Q1 25
$4.8M
$77.1M
Q4 24
$9.4M
$77.3M
Q3 24
$6.6M
$61.1M
Q2 24
$5.0M
$49.1M
Q1 24
$11.7M
$49.5M
Total Debt
FLNT
FLNT
RIGL
RIGL
Q4 25
$34.6M
$52.5M
Q3 25
$26.0M
$60.0M
Q2 25
$23.2M
$60.0M
Q1 25
$25.6M
$60.0M
Q4 24
$35.6M
$60.0M
Q3 24
$37.9M
$60.0M
Q2 24
$33.3M
$60.0M
Q1 24
$31.0M
$60.0M
Stockholders' Equity
FLNT
FLNT
RIGL
RIGL
Q4 25
$18.2M
$391.5M
Q3 25
$21.6M
$117.6M
Q2 25
$19.1M
$81.9M
Q1 25
$22.0M
$18.6M
Q4 24
$25.0M
$3.3M
Q3 24
$20.0M
$-14.6M
Q2 24
$27.5M
$-29.9M
Q1 24
$28.7M
$-31.7M
Total Assets
FLNT
FLNT
RIGL
RIGL
Q4 25
$89.1M
$513.6M
Q3 25
$76.1M
$242.5M
Q2 25
$74.5M
$206.7M
Q1 25
$77.5M
$176.0M
Q4 24
$93.6M
$164.0M
Q3 24
$77.5M
$139.4M
Q2 24
$98.5M
$128.4M
Q1 24
$103.6M
$126.5M
Debt / Equity
FLNT
FLNT
RIGL
RIGL
Q4 25
1.90×
0.13×
Q3 25
1.21×
0.51×
Q2 25
1.21×
0.73×
Q1 25
1.16×
3.23×
Q4 24
1.43×
18.25×
Q3 24
1.90×
Q2 24
1.21×
Q1 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLNT
FLNT
RIGL
RIGL
Operating Cash FlowLast quarter
$2.8M
$22.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLNT
FLNT
RIGL
RIGL
Q4 25
$2.8M
$22.0M
Q3 25
$-7.3M
$24.0M
Q2 25
$935.0K
$30.5M
Q1 25
$2.1M
$-893.0K
Q4 24
$-2.1M
$14.5M
Q3 24
$1.2M
$21.7M
Q2 24
$-13.1M
$302.0K
Q1 24
$-132.0K
$-5.0M
Free Cash Flow
FLNT
FLNT
RIGL
RIGL
Q4 25
Q3 25
$-7.3M
Q2 25
Q1 25
Q4 24
Q3 24
$1.2M
Q2 24
Q1 24
FCF Margin
FLNT
FLNT
RIGL
RIGL
Q4 25
Q3 25
-15.6%
Q2 25
Q1 25
Q4 24
Q3 24
1.9%
Q2 24
Q1 24
Capex Intensity
FLNT
FLNT
RIGL
RIGL
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
FLNT
FLNT
RIGL
RIGL
Q4 25
0.08×
Q3 25
0.86×
Q2 25
0.51×
Q1 25
-0.08×
Q4 24
1.01×
Q3 24
1.75×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLNT
FLNT

Commerce Media Solutions$34.7M56%
Owned And Operated$21.3M34%
Call Solutions$3.8M6%
Ad Parlor$2.0M3%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons